Ottobock SE & Co. KGaA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
  Duderstadt, 07 October 2025   Total offer volume amounts to EUR 807,587,418.00 and comprises the placement of 1,515,151 newly issued bearer shares, 9,125,000 existing bearer shares, as well as 1,596,022 bearer shares in connection with an over-allotment option Final offer price implies a market capitalization of approximately EUR 4.2 billion Free float expected to amount to 19.12%, current shareholders expected to retain at least 80.88% of the share capital First day of trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange scheduled for 9 October 2025   Ottobock SE & Co. KGaA (the “Company”) – the global MedTech champion of the Custom Orthotics and Prosthetics (O&P) industry – has set the final price for its initial public offering (the “IPO”) today at EUR 66.00 per share. A total of 12,236,173 shares are being placed with investors, comprising 1,515,151 newly issued bearer shares from a capital increase against cash contributions, 9,125,000 existing bearer shares from the holdings of Näder Upside Vermögensverwaltungs GmbH (the “Selling Shareholder”) and 1,596,022 additional existing bearer shares from the holdings of the Selling Shareholder in connection with an over-allotment (the “Greenshoe Option”). Oliver Jakobi, CEO of Ottobock, said: “The IPO marks an important milestone for Ottobock. For more than 100 years, the Company has stood for innovation and responsibility towards the people we serve. With the IPO, we are creating the foundation to carry this tradition into the future – with investments in cutting-edge technologies, sustainable growth, and the clear ambition to set new standards in Human Bionics.”

Based on the final offer price, the total placement volume amounts to EUR 807,587,418.00, assuming full exercise of the Greenshoe Option. The Company’s market capitalization is expected to amount to approximately EUR 4.2 billion. The free float is expected to amount to 19.12%, assuming full exercise of the Greenshoe Option. The Company’s current shareholders are expected to retain at least 80.88% of the Company’s share capital. Retail investors that placed orders with syndicate banks were allocated approximately 4.7% of the total placement volume, amounting to 574,145 shares in the aggregate. All orders placed by retail investors with syndicate banks were allocated according to the following allocation key: Up to an amount of 20 shares, each order received a full allocation. Higher orders were allocated approximately 12% of the shares exceeding this amount, subject to a cap of 500 shares. The “Principles for the Allotment of Share Issues to Private Investors“ (Grundsätze für die Zuteilung von Aktienemissionen an Privatanleger) issued by the German Commission of Stock Exchange Experts (Börsensachverständigenkommission) of the German Federal Ministry of Finance (Bundesministerium der Finanzen) were followed and the allocation to retail investors in connection with the offering followed the same criteria for all syndicate banks and their affiliated institutions. The lock-up period for the Company, the existing shareholders and certain members of the Company’s governing bodies is 180 days following the first day of trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange. Trading of the Company’s shares on the regulated market (Prime Standard) of the Frankfurt Stock Exchange is expected to start on 9 October 2025 under the trading symbol OBCK and the ISIN DE000BCK2223. Settlement and closing of the offering are planned for 10 October 2025. BNP PARIBAS, Deutsche Bank and Goldman Sachs are acting as joint global coordinators and joint bookrunners. BofA Securities and UBS act as senior bookrunners, and Jefferies and UniCredit are acting as additional joint bookrunners. COMMERZBANK has been appointed as senior co-lead manager. DZ BANK and LBBW have been appointed as co-lead managers. Lilja & Co. is acting as financial advisor to Näder Holding and Ottobock.

Further information is available at https://investors.ottobock.com.  
About Ottobock Ottobock, a global MedTech champion, combines over 100 years of tradition with outstanding innovative strength in the fields of prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative fitting solutions for people with limited mobility and is driving the digitalisation of the industry. Founded in Berlin in 1919, the company has business activities in 45 countries with nearly 9,300 employees (FTEs) worldwide and operates the largest international patient care network with around 400 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock’s mission of improving freedom of movement, quality of life and independence is deeply rooted in the company's DNA, as is its social commitment: Ottobock has been a partner and supporter of the Paralympics since 1988.   Investor contact:   Ottobock SE & Co. KGaA
Julia Hartmann
VP Investor Relations
Mobile +49 151 556 848 07
Julia.Hartmann@ottobock.de
  Media contacts: Ottobock SE & Co. KGaA
Merle Florstedt     
Head of Corporate Communications  
Mobile +49 151 441 616 25
Merle.Florstedt@ottobock.de   Kekst CNC
Knut Engelmann
Mobile +49 174 234 2808
Knut.Engelmann@kekstcnc.com   Important Notice This announcement is not and does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America, Australia, Canada or Japan, or any other jurisdiction in which such offer may be restricted. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, or otherwise transferred, directly or indirectly, in or into the United States of America absent such registration, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the Securities Act, and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the securities in the United States of America. This announcement is an advertisement and not a prospectus. Investors should not purchase or subscribe for any securities in Ottobock SE & Co. KGaA (“Ottobock” or the “Company”) referred to in this announcement except on the basis of information in the prospectus issued by the company in connection with the offering of such securities. Copies of the prospectus are available free of charge from the issuer or on https://investors.ottobock.com. The approval of the prospectus by the German Financial Supervisory Authority (BaFin) should not be understood as an endorsement of the securities. It is recommended that potential investors read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the securities. This announcement is directed at and/or for distribution in the United Kingdom only to (i) persons who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities falling within article 49(2)(a) to (d) of the Order (all such persons are referred to herein as “relevant persons”). This announcement is directed only at relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons. Forward-looking Statements This announcement may contain “forward-looking statements”. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as “will”, “anticipates”, “aims”, “could”, “may”, “should”, “expects”, “believes”, “intends”, “plans”, “prepares” or “targets” (including in their negative form or other variations). By their nature, forward-looking statements are inherently predictive, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. There are a number of factors that could cause actual results, performance and developments to differ materially from those expressed or implied by these forward-looking statements. All subsequent written or oral forward-looking statements attributable to Ottobock or its respective affiliates, or any persons acting on their behalf are expressly qualified in their entirety by the factors referred to above. No assurances can be given that the forward-looking statements in this document will be realised. Any forward-looking statements are made of the date of this announcement.  Subject to compliance with applicable law and regulations, neither (i) Ottobock, nor (ii) BNP PARIBAS, Deutsche Bank Aktiengesellschaft, Goldman Sachs Bank Europe SE, BofA Securities Europe SA, UBS AG London Branch, Jefferies GmbH, UniCredit Bank GmbH, COMMERZBANK Aktiengesellschaft, DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, Landesbank Baden-Württemberg (together, the “Underwriters”) nor their respective affiliates intend to update, review, revise or conform any forward-looking statement contained in this announcement to actual events or developments whether as a result of new information, future developments or otherwise, and do not undertake any obligation to do so. This announcement does not constitute investment, legal, accounting, regulatory, taxation or other advice. No person is authorised to give any information or to make any representation not contained in and not consistent with the announcement and, if given or made, such information or representation must not be relied upon as having been authorised by or on behalf of the Company or any Underwriter. This announcement does not purport to contain all information required to evaluate Ottobock and/or its financial position. Financial information (including percentages) has been rounded according to established commercial standards. Certain market positioning data about Ottobock included in this announcement is sourced from or based on third-party sources. Third-party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the fairness, quality, accuracy, relevance, completeness or sufficiency of such data. Such research and estimates, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change without notice. Accordingly, Ottobock and the Underwriters expressly disclaim any responsibility for, or liability in respect of, such information and undue reliance should not be placed on such data. The Underwriters are acting exclusively for Ottobock and the Selling Shareholder and no one else in connection with the offering of the shares of Ottobock (the “Offering”). They will not regard any other person as their respective clients in relation to the Offering and will not be responsible to anyone other than Ottobock and the Selling Shareholder for providing the protections afforded to its clients, nor for providing advice in relation to the Offering, the contents of this announcement or any transaction, arrangement or other matter referred to herein. In connection with the Offering, the Underwriters and their respective affiliates may take up a portion of the shares offered in the Offering as a principal position and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts such shares and other securities of Ottobock or related investments in connection with the Offering or otherwise. Accordingly, references in the securities prospectus to the shares being offered, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or acquisition, placing or dealing by, the Underwriters and their respective affiliates acting in such capacity. In addition, the Underwriters and their respective affiliates may enter into financing arrangements (including swaps or contracts for differences) with investors in connection with which the Underwriters and their respective affiliates may from time to time acquire, hold or dispose of shares of Ottobock. The Underwriters do not intend to disclose the extent of any such investment or transactions, other than in accordance with any legal or regulatory obligations to do so. None of the Underwriters nor any of their respective affiliates nor any of the Underwriters’ or such affiliates' directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this release (or whether any information has been omitted from the release) or any other information relating to Ottobock and/or its subsidiaries, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available, or for any loss howsoever arising from any use of this release or its contents or otherwise arising in connection therewith. To cover potential over-allotments, Näder Upside Vermögensverwaltungs GmbH (the “Selling Shareholder”) has agreed to make available a specified number of the Company's shares to the Underwriters. In addition, the Selling Shareholder has granted the Underwriters an option to acquire a number of the Company’s shares equal to the number of shares allotted to cover over-allotments during the Stabilization Period (as defined below). In connection with the placement of the Company’s shares, Goldman Sachs Bank Europe SE will act as the stabilization manager and may, as stabilization manager, make over-allotments and take stabilization measures in accordance with legal requirements (Art. 5(4) and (5) of Regulation (EU) No 596/2014 in conjunction with Articles 5 through 8 of Commission Delegated Regulation (EU) 2016/1052) to support the market price of the Company’s shares and thereby counteract any selling pressure. The stabilization manager is under no obligation to take any stabilization measures. Therefore, stabilization may not necessarily occur and may cease at anytime. Such measures may be taken on the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) from the date when trading in the Company’s shares is commenced on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), expected on or around 9 October 2025, and must be terminated no later than 30 calendar days after this date (the "Stabilization Period"). Stabilization transactions aim at supporting the market price of Company’s shares during the Stabilization Period. These measures may result in the market price of Company’s shares being higher than would otherwise have been the case. Moreover, the market price may temporarily be at an unsustainable level. The information contained in this release is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this release or its accuracy, fairness or completeness. The date of the admission to trading of shares of Ottobock on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) with simultaneous admission to the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) (together, the "Admission") may be influenced by things such as market conditions. There is no guarantee that Admission will occur and no financial decision should be based on the intentions of Ottobock in relation to Admission at this stage. Acquiring investments to which this release relates may expose an investor to a significant risk of losing all of the amount invested. Persons considering making such investments should consult an authorised person specializing in advising on such investments. This release does not constitute a recommendation concerning the Offering. The value of shares can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the Offering for the person concerned.